Navigation Links
Genetic predictor of breast cancer response to chemotherapy
Date:5/11/2012

Chemotherapy is a major first line defense against breast cancer. However a patient's response is often variable and unpredictable. A study published in BioMed Central's open access journal BMC Medical Genomics shows that 'gene expression signatures' for TOP2A and β-tubulin can be used to predict the outcome of chemotherapy.

The goal of personalized medicine in cancer treatment is to target therapy to the characteristics of the individual tumor. For example Herceptin treatment is of most benefit to patients whose cancer is driven by HER2 and antiestrogens benefit patients whose breast cancer is hormonally driven. Gene signatures are increasingly available for different cancer types and can be used to predict patient prognosis.

Researchers from McMaster University, in association with the Juravinski Hospital and Cancer Center, analyzed the expression of the enzyme TOP2A (DNA topoisomerase) and β-tubulin, which are the targets of commonly used chemotherapy drugs (anthracycline and taxane) in hundreds of breast tumors. Combining the results from the tumor samples analyses allowed the researchers to build gene expression 'signatures' that measure the susceptibility of tumor cells to chemotherapy.

Both of the 'signatures' were separately able to predict which patients achieved a complete response (where invasive or metastatic cancer could no longer be detected) and together the two indices together were even more accurate at predicting response to chemotherapy.

Prof John Hassell, who led this study, commented, " Our results clearly demonstrate the practicality of using gene expression to personalize chemotherapy treatment for breast cancer patients. Identifying patients who will not benefit from a specific treatment means that they can be moved to a different treatment plan, and the earlier appropriate treatment is started the more likely it is that the patients will benefit from it."


'/>"/>
Contact: Dr. Hilary Glover
hilary.glover@biomedcentral.com
44-020-319-22370
BioMed Central
Source:Eurekalert

Page: 1

Related medicine news :

1. Advanced genetic screening method may speed vaccine development
2. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
3. Some women may be genetically predisposed to smoking-related hot flashes
4. Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients
5. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
6. Research Gets Closer to Genetic Roots of Glaucoma
7. Genetic variants, tobacco exposure and lung cancer risk
8. Study of half siblings provides genetic clues to autism
9. Certain Genetic Regions May Be Tied to Osteoporosis
10. Head, Body Lice Are Genetically Very Similar
11. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 “Bivalent, Heteronomy and Natural Killer ... hottest metal bands ~ homeostatic CS science is the ... July Roundup, new on the Bryan William Brickner ... and the cannabinoid system (CS). The line-up links to ... wellness: three directly on homeostasis, two each on the ...
(Date:7/31/2014)... latest blog post, Best Drug Rehabilitation , which offers ... a stay in rehab can make a big difference in ... nine secrets that addicts don’t want others to know. ... addict from a mile away, and totally understand what’s going ... Per Wickstrom . “However, take it from me: spotting addicts ...
(Date:7/31/2014)... 31, 2014 Continuing Education Company ... inaugural Clinical Issues in Primary Care Continuing ... 2014 at the Wailea Beach Marriott Resort and Spa ... has been developed for today's Primary Care practitioners. In ... topics," says Barbara Lyons, VP Education. , The agenda ...
(Date:7/30/2014)... Denver, Colorado (PRWEB) July 30, 2014 ... the skiers wearing orange vests emblazoned with “Blind Skier.” ... Colorado slopes through Foresight Ski Guides , a ... with visually impaired and blind participants (VIPs) for snow ... interested in guiding can learn more and pick up ...
(Date:7/30/2014)... July 31, 2014 Responding to ... environment more responsive to an increasingly diverse patient ... experience and scholarly expertise to the publication of ... care professions: "Diversity and Cultural Competence in Health ... L. Dreachslin, PhD, a professor in the Management ...
Breaking Medicine News(10 mins):Health News:Homeostatic Cannabinoid Science ~ Publius’ July Roundup on the Bryan William Brickner Blog 2Health News:Latest Best Drug Rehabilitation Blog Posts Focuses on Nine Secrets Addicts Don’t Want Others to Know 2Health News:Latest Best Drug Rehabilitation Blog Posts Focuses on Nine Secrets Addicts Don’t Want Others to Know 3Health News:Clinical Issues in Primary Care Continuing Medical Education (CME) Conference - October 13-17, 2014 in Maui, Hawaii - Agenda Released 2Health News:Clinical Issues in Primary Care Continuing Medical Education (CME) Conference - October 13-17, 2014 in Maui, Hawaii - Agenda Released 3Health News:Colorado Non-Profit Foresight Ski Guides Seeking Applications for Blind and Visually Impaired Skiers and Guides for Vail Ski Season 2Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 2Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 3
... Health & Science University researchers have determined exactly how much ... results of this research are being presented from 5 p.m. ... for Therapeutic Radiology and Oncology in Boston. , "Many ... that it doesn,t move in relation to the bony pelvis, ...
... is playing an ever smaller role in the treatment ... and safe radiation therapy techniques. Progress in radiation technology ... This is according to Professor Freek Beekman, who will ... on Wednesday, 24 September. , In his inaugural ...
... bacteria that drive the ailment, study shows , , WEDNESDAY, ... sweet relief to chronic sinusitis sufferers, new Canadian research ... attack the bacteria that cause the discomforting disorder. , ... natural anti-microbial dressing for infected wounds for hundreds of ...
... 24 TransEnterix, an,early-stage, privately-held medical device company ... the Board of Directors has,named Todd M. Pope ... Pope has spent nearly 20 years in the ... neurovascular, and,laparoscopic surgery., Mr. Pope, 43, was ...
... Indianapolis speech, INDIANAPOLIS, Sept. 24 Today Eli ... is set to become the first,pharmaceutical research company to ... At a speech before the Economic Club of Indiana ... outlined the,company,s plans to launch an online registry of ...
... Longstanding Barriers to ... Hearing Better, ... a unique option for people dealing with mild to moderate,hearing loss. ... hearing loss, while concerns about cost,commitments, and inconvenience contribute to only ...
Cached Medicine News:Health News:OHSU Cancer Institute researchers study breathing during radiation 2Health News:Open cancer surgery set to become a thing of the past 2Health News:A Honey of a Sinusitis Treatment 2Health News:A Honey of a Sinusitis Treatment 3Health News:TransEnterix Inc. Names Experienced Medical Device Executive Todd M. Pope as President, CEO 2Health News:Lilly Set to Become First Pharmaceutical Research Company to Disclose Physician Payments 2Health News:Lilly Set to Become First Pharmaceutical Research Company to Disclose Physician Payments 3Health News:Songbird Hearing Provides Revolutionary Alternative for Those Dealing With Hearing Loss 2Health News:Songbird Hearing Provides Revolutionary Alternative for Those Dealing With Hearing Loss 3
(Date:7/30/2014)... 2014  Hologic, Inc. (NASDAQ: HOLX ) ... ended June 28, 2014. Third Quarter Financial ... to $632.6 million, reflecting operational growth of 0.5% and ... same period in the prior year. , Revenues ... Breast Health revenues grew 3.5%. , GYN Surgical ...
(Date:7/30/2014)... July 30, 2014 In conjunction with DURECT ... financial results press release, you are invited to listen ... over the internet on Thursday, August 7, 2014 at ... A live audio webcast of the presentation will ... and clicking "Investor Relations."  If you are unable ...
(Date:7/30/2014)... , July 30, 2014 PuraMed ... and marketer of over-the-counter (OTC) medicinal and healthcare ... ® M name along with the name,s ... replaced with the trademarked name MigraPure ® ... palette of PuraMed,s homeopathic, natural migraine pain reliever ...
Breaking Medicine Technology:Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3
... R.I., Oct. 29 CVS Caremark Corporation (NYSE: ... and Chief Operating Officer, and Per Lofberg, Executive Vice ... at the Credit Suisse Annual Healthcare Conference in Phoenix, ... a.m. local time (11:30 a.m. EST). An ...
... PALO ALTO, Calif. and SPRINGFIELD, Va. Oct. 29 Varian ... that CURE Foundation has placed an order for five Varian ... CURE Foundation, which placed the order in September, ... clinics on the U.S. East Coast during 2011.   ...
Cached Medicine Technology:CURE Foundation Selects Varian Medical Systems to Supply Radiotherapy Technology for Five New Cancer Centers 2
The under-patient design of the pediatric full access blanket warms even the tiniest patients while allowing full access for surgeons and staff....
This blanket gently surrounds the child with temperature-controlled air. Use one or both of the enclosed clear plastic drapes to keep warmed air near the skin....
2-ply material consisting of polyethylene film inner layer and non-woven outer layers....
The multi-access blanket offers access to any part of the patient's body while providing full patient coverage....
Medicine Products: